IGF2BP3 and laryngeal squamous cell carcinoma: RBM15 has been manifested to mediate m6A modification of transmembrane BAX inhibitor motif containing 6 (TMBIM6) mRNA via depending on the reader protein IGF2BP3 in laryngeal squamous cell carcinoma [27].